Palliative treatment for advanced or metastatic osteosarcoma.
Merimsky
Ofer
O
Unit of Soft Tissue and Bone Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. oferm@tasmc.health.gov.il
Kollender
Yehuda
Y
Inbar
Moshe
M
Meller
Isaac
I
Bickels
Jacob
J
D000671:Amputation, Surgical; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000401:mortality / Q000628:therapy*; D001932:Brain Neoplasms / Q000556:secondary; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000556:secondary; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000628:therapy; D012516:Osteosarcoma / Q000401:mortality / Q000628:therapy*; D010166:Palliative Care / Q000379:methods*; D011013:Pneumonectomy; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome; D000093542:Gemcitabine
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D003841:Deoxycytidine; D004317:Doxorubicin; D002945:Cisplatin; D007069:Ifosfamide; D000093542:Gemcitabine